Plavix unvoidable to face with influx of generics next year.

Published: 2007-01-02 06:59:00

Updated: 2007-01-02 06:59:00

A lot of local drug companies are going to launch many generic drugs of Plavix (clopidogrel), an anti-platelet drug supplied by Sanofi-Aventis and BMS Korea, next year to provoke a great competition on the market.

Plavix sales occupied a majority ratio of the Sanofi-Aventis Korea business, ran...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK